In the UK alone, over 5 million people are at risk of developing diabetic retinopathy, a condition that can cause blindness through delayed, slow and/or inconsistent diagnoses. Our Al-powered tool enables easy, fast and reliable diagnosis and prediction, thereby saving the eyesight of thousands of diabetic patients.
The existing Diabetic Retinopathy diagnosis and prevention process is slow, labour-intensive and prone to human error. Our innovative award-winning solution addresses these challenges.
The high volume of patients is challenging the healthcare system and increases treatment costs
We minimise the time and effort needed to diagnose Diabetic Retinopathy and grade patients
Invented by experts who have spent time in hospitals and garnered experience across all walks of the medical field, DRAI is the quintessential solution to anything involving detection, diagnosis, or predictions centered on diabetic care. Here’s how it can help:
Our Diabetic Retinopathy Artificial Intelligence assistance tool (DRAI) is a real-time medical software powered by AI that helps in the early and accurate diagnosis of diseases and thereafter the treatment of these diseases.
We have contributed to the NHS national screening programme that delivered a number of solutions to assist healthcare professionals. Our AI helped them to identify hidden insights in data and assisted clinicians in making an informed decision for the right treatments and follow ups.
By tapping into the right data, it is possible to save a significant amount of time while delivering a professional experience. Choosing the right treatment can make a big difference and having access to a wealth of validated information will help professionals to take the right decisions.
Sign up our newsletter to get update news and article about company.